Mediator

Role

Indications

Reactions

Secondary

Product Used For Unknown Indication	24.1%
Diabetes Mellitus	14.7%
Drug Use For Unknown Indication	12.2%
Type 2 Diabetes Mellitus	10.0%
Hypertension	9.9%
Narcolepsy	5.2%
Depression	4.6%
Bipolar Disorder	3.1%
Overweight	2.6%
Hypercholesterolaemia	1.6%
Tremor	1.6%
Depressive Symptom	1.4%
Dyslipidaemia	1.4%
Hyperlipidaemia	1.4%
Systemic Lupus Erythematosus	1.4%
Ill-defined Disorder	1.1%
Migraine	1.0%
Hypothyroidism	0.9%
Weight Control	0.9%
Central Obesity	0.8%

Pulmonary Arterial Hypertension	18.8%
Tricuspid Valve Disease	11.7%
Aortic Valve Incompetence	10.4%
Tricuspid Valve Incompetence	8.4%
Aortic Valve Disease	7.8%
Cardiac Valve Disease	5.8%
Dyspnoea Exertional	4.5%
Mitral Valve Incompetence	4.5%
Pancreatitis Acute	4.5%
Dyspnoea	3.2%
Hepatic Cirrhosis	3.2%
Ventricular Hypokinesia	2.6%
Hypoglycaemia	1.9%
Hypothermia	1.9%
Interstitial Lung Disease	1.9%
Portal Hypertension	1.9%
Pulmonary Hypertension	1.9%
Rash Scarlatiniform	1.9%
Asthenia	1.3%
Bradycardia	1.3%

Concomitant

Drug Use For Unknown Indication	29.7%
Hypertension	11.0%
Depression	7.7%
Rheumatoid Arthritis	7.7%
Diabetes Mellitus	4.9%
Hypercholesterolaemia	4.9%
Overweight	4.1%
Type 2 Diabetes Mellitus	3.8%
Osteoporosis	3.3%
Dyslipidaemia	2.8%
Ill-defined Disorder	2.6%
Insomnia	2.6%
Pain	2.6%
Product Used For Unknown Indication	2.6%
Hyperlipidaemia	2.0%
Ischaemic Cardiomyopathy	2.0%
Diabetes Mellitus Non-insulin-dependent	1.5%
Myalgia	1.5%
Weight Control	1.5%
Hypertriglyceridaemia	1.3%

Metastatic Neoplasm	13.0%
Malaise	9.1%
Aortic Valve Incompetence	6.5%
Tricuspid Valve Incompetence	6.5%
Weight Increased	5.2%
White Blood Cell Count Increased	5.2%
Acute Generalised Exanthematous Pustulosis	3.9%
Atrial Fibrillation	3.9%
Congestive Cardiomyopathy	3.9%
Dyspnoea	3.9%
Mental Disorder	3.9%
Mitral Valve Incompetence	3.9%
Pancreatitis Acute	3.9%
Pancreatitis Necrotising	3.9%
Renal Impairment	3.9%
Rhabdomyolysis	3.9%
Somnolence	3.9%
Thrombocytopenia	3.9%
Transient Ischaemic Attack	3.9%
Vomiting	3.9%